View : 16 Download: 0

VERY EARLY MOLECULAR RESPONSE (VEMR) WITH FRONTLINE DASATINIB TREATMENT IS A STRONG PREDICTOR OF LONG-TERM BCR-ABL1 TRANSCRIPT LEVELS IN CHRONIC MYELOID LEUKEMIA PATIENTS: PCR-DEPTH STUDY

Title
VERY EARLY MOLECULAR RESPONSE (VEMR) WITH FRONTLINE DASATINIB TREATMENT IS A STRONG PREDICTOR OF LONG-TERM BCR-ABL1 TRANSCRIPT LEVELS IN CHRONIC MYELOID LEUKEMIA PATIENTS: PCR-DEPTH STUDY
Authors
Lee, W-S.Kim, H-J.Kong, J. H.Kim, H.Do, Y. R.Kwak, J-Y.Oh, S.Kim, S. H.Kim, J-A.Zang, D. Y.Mun, Y-C.Won, Y-W.Lee, S-E.Choi, S-Y.Kim, S-H.Choi, M-Y.Kim, D-W.
Ewha Authors
문영철
SCOPUS Author ID
문영철scopus
Issue Date
2017
Journal Title
HAEMATOLOGICA
ISSN
0390-6078JCR Link
Citation
vol. 102, pp. 434 - 434
Publisher
FERRATA STORTI FOUNDATION
Indexed
SCI; SCIE; SCOPUS WOS
Appears in Collections:
의학전문대학원 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE